Hemosol B0 (Calcium, Lactic Acid, Magnesium, Sodium, Chloride Ion, Hydrogen Carbonate)

Hemosol B0 is indicated for several clinical situations where fluid and electrolyte management is required.

• Replacement of fluid losses due to surgery, trauma, or burns.
• Correction of electrolyte imbalances such as hypocalcemia, hypomagnesemia, or hyponatremia.
• Management of metabolic acidosis by providing bicarbonate precursors.
• Support during renal replacement therapy or dialysis.
• Use as a carrier solution for the administration of other intravenous medications.

Side effects of Hemosol B0 are generally related to its electrolyte composition and infusion characteristics.

Common

• Mild irritation at the infusion site.
• Transient changes in blood pressure (hypotension or hypertension).
• Slight increase in serum calcium or magnesium levels.
• Nausea or mild gastrointestinal discomfort.

Serious

• Severe hypercalcemia or hypermagnesemia.
• Rapid shifts in serum electrolytes leading to cardiac arrhythmias.
• Anaphylactic or severe allergic reactions.
• Fluid overload causing pulmonary edema.

When using Hemosol B0, clinicians should consider several safety measures.

• Verify patient electrolyte status and renal function before initiation.
• Adjust infusion rate in patients at risk of fluid overload or heart failure.
• Monitor serum calcium, magnesium, sodium, and bicarbonate levels during therapy.
• Use caution in patients with known hypersensitivity to any component of the solution.
• Avoid rapid bolus administration unless specifically indicated.
• Ensure proper aseptic technique to prevent infection.

Hemosol B0 may interact with other medications that affect electrolyte balance or cardiac function.

Avoid

• Concurrent use of high-dose calcium or magnesium supplements that could cause hypercalcemia or hypermagnesemia.
• Administration with drugs that prolong the QT interval when electrolyte disturbances are present.

Use with caution

• Loop diuretics, which may increase electrolyte loss.
• ACE inhibitors or ARBs, which can affect potassium and sodium balance.
• Anticoagulants, as rapid volume changes may influence coagulation status.
• Other intravenous solutions containing overlapping electrolytes, to prevent cumulative dosing errors.